Document Detail

A budget impact analysis comparing a Hydrofiber® dressing to an alginate dressing in managing exuding venous leg ulcers in France.
MedLine Citation:
PMID:  23020759     Owner:  NLM     Status:  Publisher    
An Excel model was developed to compare total costs (including primary and secondary dressings only) of Hydrofiber® dressing (2010 branded price) versus an alginate dressing (generic or branded price) in managing exuding venous leg ulcers considering mean wear time and mean duration of exudate management phase, from the French Social Security perspective over 5 years (2011-2015). Budget impact (based on prevalence of venous leg ulcers in France) was estimated as the difference between scenario 1 (Hydrofiber® versus alginate dressing usage proportion increasing slightly per year) and Scenario2 (proportion remaining at 2010 levels). Annual costs and net savings per patient for the dressings were calculated in analyses 1 and 2. Analysis 1 (28-day mean exudate management phase for both Hydrofiber® and alginate dressing groups): total costs 66·82€ Hydrofiber®, 70·08€ generic alginate, 77·0€ branded alginate; net savings 3·26€ and 10·18€ for Hydrofiber® versus generic and branded alginate. Analysis 2 (mean exudate management phase of 22·2 versus 28 days for Hydrofiber® versus alginate): total costs 52·92€, 70·08€ and 77·0€, and net savings 17·10€ and 24·02€, accordingly. Total cost savings (budget impact scenario 1 minus scenario 2): Analysis 1 - 223 107€ and 696 304€ for Hydrofiber® versus generic and branded alginate dressings, respectively; Analysis 2 - 1 169 845€ and 1 643 042€ accordingly. Sensitivity analyses indicated that results are reliable. This conservative analysis shows that effective exudate management using Hydrofiber® dressing can produce sizeable cost savings.
Songkai Yan; Xavier Colin; Carole Coudray-Omnès; Pascale Guido-Morin; Dheerendra R Kommala
Related Documents :
23020759 - A budget impact analysis comparing a hydrofiber® dressing to an alginate dressing in m...
16459499 - Re-engineering colles: form, function and fragility fractures.
16202949 - An analysis of recent antitrust issues affecting specialty practice: is dermatology imm...
2073569 - Overview of bioethics in mexico.
22382089 - On rat poison and human medicines: personalizing warfarin therapy.
23690319 - Cost estimates for operating a primary care practice facilitation program.
16619939 - Management of brain injury in non-elite field hockey and australian football--a qualita...
17207159 - Traditional practices and exposure to bodily fluids in lusaka, zambia.
8912099 - Silverpoint drawing for scientific illustration.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-10-1
Journal Detail:
Title:  International wound journal     Volume:  -     ISSN:  1742-481X     ISO Abbreviation:  Int Wound J     Publication Date:  2012 Oct 
Date Detail:
Created Date:  2012-10-1     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101230907     Medline TA:  Int Wound J     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Copyright Information:
© 2012 The Authors. International Wound Journal © 2012 Blackwell Publishing Ltd and Inc.
S Yan, MS, Health Economics Strategy & Communications, ConvaTec, Inc., Skillman, NJ, USA X Colin, MSc, Cemka-Eval, Bourg-la-Reine, France C Coudray-Omnès, PharmD, Cemka-Eval, Bourg-la-Reine, France P Guido-Morin, PharmD, Laboratoires ConvaTec, La Garenne-Colombes, France DR Kommala, MD, ConvaTec, Inc., Skillman, NJ, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Patients' perceptions of podoconiosis causes, prevention and consequences in East and West Gojam, No...
Next Document:  Influence of nitrate supplementation on VO(2) kinetics and endurance of elite cyclists.